| Tag | Content |
|---|
EnhancerAtlas ID | HS109-13298 |
Organism | Homo sapiens |
Tissue/cell | Kasumi-1 |
Coordinate | chr2:225758930-225759470 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Rhox11 | MA0629.1 | chr2:225759026-225759043 | TTTCTTTACAGCATCAT | - | 6.08 | | SPI1 | MA0080.4 | chr2:225759221-225759235 | AGAAAGAGGAAGTC | + | 6.21 | | SPIC | MA0687.1 | chr2:225759221-225759235 | AGAAAGAGGAAGTC | + | 6.67 | | Sox6 | MA0515.1 | chr2:225758971-225758981 | CCATTGTTTT | + | 6.02 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_11129 | chr2:225757515-225763655 | CD20 | | SE_18264 | chr2:225757474-225760548 | CD4p_CD25-_Il17-_PMAstim_Th |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 225759181 | 225759393 | | chr2 | 225759100 | 225759430 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I224893 | chr2 | 225758527 | 225760539 |
|
Enhancer Sequence | GCAATAATGT CCGGGATTGG TTTTTTCTAG AGATGCTTTC TCCATTGTTT TAACAGAGGA 60
AGAATACTGT GAATGTGAAA TCTCTAATTT GCTTTCTTTC TTTACAGCAT CATGAATATA 120
AGGAAAGATG AACAGTGTTT GGGGATACAG CCACTGAAGA GTGTAATGGA CCTAAAGATG 180
GTGGGAACAC ATTTAGTTAA AAGGATGGCT AAATACGGCT GTCTCCATCC TCTCAACTTG 240
AGATGCAGTC TCCCAACTTC CGAGTTGTAA CCACTTCTCA GAACTATTTT CAGAAAGAGG 300
AAGTCCTGAT GTTAAAAGAT GCTTTGCTTT TCAGTTGTGC CTACAAAAAC TGTGTCATGA 360
ACACCCAGAC ATTCTGAATG TAACAATTAC TCATGAAAGC TTAGGGTGTG GTAAACCTTC 420
CCAACATGAA GTTGCAAGAG CTTGTCTATC AGCAGGGATT CAAGTCAAAA AGAATGCTCA 480
AAGATCTGGT AAACGTTACT GTTCAGTGTT TTGAAAAAAG ATTTGCAGTT TAGAAGGGAC 540
|
